DrugPatentWatch Database Preview
Taro Pharm Company Profile
What is the competitive landscape for TARO PHARM, and when can generic versions of TARO PHARM drugs launch?
TARO PHARM has sixty-three approved drugs.
There are six US patents protecting TARO PHARM drugs. There are two tentative approvals on TARO PHARM drugs.
Summary for Taro Pharm
| US Patents: | 6 |
| Tradenames: | 49 |
| Ingredients: | 45 |
| NDAs: | 63 |
| Patent Litigation for Taro Pharm: | See patent lawsuits for Taro Pharm |
Drugs and US Patents for Taro Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro Pharms North | PSORCON | diflorasone diacetate | CREAM;TOPICAL | 020205-001 | Nov 20, 1992 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Taro Pharm | NYSTATIN | nystatin | SUSPENSION;ORAL | 062876-001 | Feb 29, 1988 | AA | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Taro Pharm Inds Ltd | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | CREAM;TOPICAL | 040039-001 | Nov 26, 1997 | AT | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Taro Pharm | AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | TABLET;ORAL | 075424-002 | Dec 18, 2002 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Taro Pharm Inds Ltd | DESLORATADINE | desloratadine | SOLUTION;ORAL | 202592-001 | Jun 30, 2015 | AA | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Taro Pharm | FELBAMATE | felbamate | SUSPENSION;ORAL | 206314-001 | Jun 16, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Taro Pharm | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 040301-007 | Jul 15, 1999 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Taro Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Taro Pharms | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 5,919,479 | ➤ Sign Up |
| Taro Pharms | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | 5,990,100 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for TARO PHARM drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
| ➤ Subscribe | Topical Lotion | 0.5% | ➤ Subscribe | 2011-03-16 |
International Patents for Taro Pharm Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 2007126462 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 0122907 | ➤ Sign Up |
| Japan | 2003510259 | ➤ Sign Up |
| China | 101287374 | ➤ Sign Up |
| China | 103087095 | ➤ Sign Up |
| Australia | 7719800 | ➤ Sign Up |
| China | 101219108 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Taro Pharm Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 1458369/01 | Switzerland | ➤ Sign Up | PRODUCT NAME: ADAPALENUM + BENZOYLIS PEROXIDUM; REGISTRATION NUMBER/DATE: SWISSMEDIC 58460 19.05.2009 |
| 2013025,C1304992 | Lithuania | ➤ Sign Up | PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323 |
| C/GB10/005 | United Kingdom | ➤ Sign Up | PRODUCT NAME: ADAPALENE AND BENZOYL PEROXIDE; REGISTERED: DK 40440 20071218; UK PL10590/0057 20091111 |
| C/GB05/030 | United Kingdom | ➤ Sign Up | PRODUCT NAME: NITISINONE (2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-1,3-CYCLOHEXANEDIONE) OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/04/303/001 20050221; UK EU/1/04/303/002 20050221; UK EU/1/04/303/003 20050221 |
| C0042 | Belgium | ➤ Sign Up | PRODUCT NAME: 2-(2-BENZOYL-SUBSTITUE)-1,3-CYCLOHEXANE-DIONES; REGISTRATION NO/DATE: 8452/B 19930121 |
| C0008 | Belgium | ➤ Sign Up | PRODUCT NAME: TAZAROTENE; NAT. REGISTRATION NO/DATE: NL22604 19970922; FIRST REGISTRATION: DE - 37393.00.00 19961203 |
| C/GB08/005 | United Kingdom | ➤ Sign Up | SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB08/005 GRANTED TO MERCK SHARP + DOHME CORP. IN RESPECT OF THE PRODUCT DESLORATADINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN COMBINATION WITH PSEUDOEPHEDRINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR ESTER, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6322 DATED 21 JULY 2010 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 31 JULY 2022. |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
